Compounds > amantadine

amantadine and guanethidine

amantadine has been researched along with guanethidine in 8 studies

Research

Studies (8)

Timeframe	Studies, this research(%)	All Research%
pre-1990	3 (37.50)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (25.00)	29.6817
2010's	3 (37.50)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M	1
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM	1
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Jones, LH; Nadanaciva, S; Rana, P; Will, Y	1
Badia, A; Garcia-Sevilla, JA; Laporte, J	1
Enna, SJ; Shore, PA	1
Cox, B; Williams, CS	1

Reviews

1 review(s) available for amantadine and guanethidine

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Other Studies

7 other study(ies) available for amantadine and guanethidine

Article	Year
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors. Journal of medicinal chemistry, 2008, Nov-13, Volume: 51, Issue:21 Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship	2008
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models. Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3 Topics:	2008
FDA-approved drug labeling for the study of drug-induced liver injury. Drug discovery today, 2011, Volume: 16, Issue:15-16 Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration	2011
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships. Bioorganic & medicinal chemistry letters, 2016, 08-15, Volume: 26, Issue:16 Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone	2016
Nature of neuronal uptake and noradrenaline--adrenaline effects in the isolated rat vas deferens. European journal of pharmacology, 1975, Volume: 31, Issue:2 Topics: Amantadine; Animals; Cocaine; Computers; Depression, Chemical; Desipramine; Epinephrine; Guanethidine; In Vitro Techniques; Male; Neurons; Norepinephrine; Rats; Vas Deferens	1975
On the nature of the adrenergic neuron extragranular amine binding site. Journal of neural transmission, 1974, Volume: 35, Issue:2 Topics: Amantadine; Amphetamine; Animals; Binding Sites; Biogenic Amines; Dopamine; Female; Guanethidine; Hydrazines; Hydroxydopamines; Myocardium; Norepinephrine; Normetanephrine; Octopamine; Phenoxybenzamine; Rats; Receptors, Adrenergic; Reserpine; Tetrabenazine; Tritium; Tyramine	1974
Cardiovascular responses to amantadine hydrochloride in the rat and rabbit. British journal of pharmacology, 1972, Volume: 46, Issue:3 Topics: Amantadine; Animals; Blood Pressure; Dopamine; Guanethidine; Heart Rate; Norepinephrine; Phentolamine; Rabbits; Rats; Reserpine	1972